Drug profile · INN
droxidopa
DROXIDOPA
droxidopa (DROXIDOPA) is a adrenergic receptor agonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — droxidopa
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
droxidopa (DROXIDOPA) is a adrenergic receptor agonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Adrenergic receptor agonist
Primary target: Adrenergic receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is droxidopa?
droxidopa (DROXIDOPA) is a adrenergic receptor agonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for droxidopa?
DROXIDOPA is a marketed brand name for droxidopa. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of droxidopa?
droxidopa has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.